DK142363B - Analogifremgangsmåde til fremstilling af 2-isopropylaminopyrimidinorthophosphat. - Google Patents
Analogifremgangsmåde til fremstilling af 2-isopropylaminopyrimidinorthophosphat. Download PDFInfo
- Publication number
- DK142363B DK142363B DK68177AA DK68177A DK142363B DK 142363 B DK142363 B DK 142363B DK 68177A A DK68177A A DK 68177AA DK 68177 A DK68177 A DK 68177A DK 142363 B DK142363 B DK 142363B
- Authority
- DK
- Denmark
- Prior art keywords
- orthophosphate
- isopropylaminopyrimidine
- preparation
- base
- analogous process
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 6
- 238000002360 preparation method Methods 0.000 title description 4
- CXEBHWXMQKIKPJ-UHFFFAOYSA-N phosphoric acid;n-propan-2-ylpyrimidin-2-amine Chemical compound OP(O)(O)=O.CC(C)NC1=NC=CC=N1 CXEBHWXMQKIKPJ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 description 14
- 241000700159 Rattus Species 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229940120124 dichloroacetate Drugs 0.000 description 4
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000003497 sciatic nerve Anatomy 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FTCYIGBVOHNHCD-UHFFFAOYSA-N isaxonine Chemical compound CC(C)NC1=NC=CC=N1 FTCYIGBVOHNHCD-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- HTQLXJWFPOVSGC-UHFFFAOYSA-N 2,2-dichloroacetic acid phosphoric acid Chemical compound ClC(C(=O)O)Cl.P(O)(O)(O)=O HTQLXJWFPOVSGC-UHFFFAOYSA-N 0.000 description 1
- MKRHSMOOEVBNPY-UHFFFAOYSA-N 2,2-dichloroacetic acid;n-propan-2-ylpyrimidin-2-amine Chemical compound OC(=O)C(Cl)Cl.CC(C)NC1=NC=CC=N1 MKRHSMOOEVBNPY-UHFFFAOYSA-N 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- -1 compound 2-isopropylaminopyrimidine orthophosphate Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- JXTHNDFMNIQAHM-UHFFFAOYSA-M dichloroacetate Chemical compound [O-]C(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-M 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6430/76A GB1525995A (en) | 1976-02-18 | 1976-02-18 | Aminopyrimidine salt |
| GB643076 | 1976-02-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK68177A DK68177A (cg-RX-API-DMAC10.html) | 1977-08-19 |
| DK142363B true DK142363B (da) | 1980-10-20 |
| DK142363C DK142363C (cg-RX-API-DMAC10.html) | 1981-03-23 |
Family
ID=9814350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK68177AA DK142363B (da) | 1976-02-18 | 1977-02-17 | Analogifremgangsmåde til fremstilling af 2-isopropylaminopyrimidinorthophosphat. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4073895A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5928548B2 (cg-RX-API-DMAC10.html) |
| AR (1) | AR215879A1 (cg-RX-API-DMAC10.html) |
| AT (1) | AT353277B (cg-RX-API-DMAC10.html) |
| AU (1) | AU507897B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE851255A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1064495A (cg-RX-API-DMAC10.html) |
| CH (1) | CH598230A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2707095C3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK142363B (cg-RX-API-DMAC10.html) |
| ES (1) | ES455945A1 (cg-RX-API-DMAC10.html) |
| FR (2) | FR2341571A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1525995A (cg-RX-API-DMAC10.html) |
| HK (1) | HK59079A (cg-RX-API-DMAC10.html) |
| IN (1) | IN145714B (cg-RX-API-DMAC10.html) |
| MX (1) | MX4494E (cg-RX-API-DMAC10.html) |
| MY (1) | MY8000069A (cg-RX-API-DMAC10.html) |
| NL (1) | NL167962C (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ183234A (cg-RX-API-DMAC10.html) |
| PT (1) | PT66191B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA77570B (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151973B (cg-RX-API-DMAC10.html) * | 1978-06-16 | 1983-09-17 | Expansia Sa | |
| IN153791B (cg-RX-API-DMAC10.html) * | 1979-03-10 | 1984-08-18 | Soc D Etudes Prod Chimique | |
| BE882836A (fr) * | 1979-05-15 | 1980-08-18 | Soc D Etudes Prod Chimique | Nouveaux derives halogenes de l'isopropylamino pyrimidine, leur preparation et leur utilisaton therapeutique |
| US4416885A (en) * | 1979-11-02 | 1983-11-22 | Huve Pierre M | Use of isopropylaminopyrimidine in the chemotherapy of muscular dystrophy, myopathy and myotonia |
| BE885851A (fr) * | 1979-11-02 | 1981-02-16 | Soc D Etudes Prod Chimique | Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie |
| JPS56152059A (en) * | 1980-04-25 | 1981-11-25 | Hitachi Ltd | Program debugging system |
| BE894517A (fr) * | 1981-10-16 | 1983-01-17 | Sod Conseils Rech Applic | Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes |
| US4868161A (en) * | 1984-06-29 | 1989-09-19 | City Of Hope | Method for promoting nerve regeneration |
| HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
| US5264435A (en) * | 1988-12-29 | 1993-11-23 | Mitsui Petrochemical Industries, Ltd. | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines |
| EP2496724B1 (en) | 2009-11-02 | 2016-09-28 | SAES Smart Materials | Ni-Ti SEMI-FINISHED PRODUCTS AND RELATED METHODS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR6235815D0 (pt) * | 1961-01-23 | 1973-05-24 | Parke Davis & Co | Processo para a producao de compostos de pirimidina |
| BE788648A (fr) * | 1971-10-09 | 1973-01-02 | Soc D Etudes Prod Chimique | Derives de l'isopropylamino pyrimidine, leur preparation leur composition et leur utilisation therapeutique |
-
1976
- 1976-02-18 GB GB6430/76A patent/GB1525995A/en not_active Expired
-
1977
- 1977-01-31 IN IN137/CAL/77A patent/IN145714B/en unknown
- 1977-02-01 ZA ZA770570A patent/ZA77570B/xx unknown
- 1977-02-02 NZ NZ183234A patent/NZ183234A/xx unknown
- 1977-02-07 AU AU22020/77A patent/AU507897B2/en not_active Expired
- 1977-02-08 MX MX775417U patent/MX4494E/es unknown
- 1977-02-09 CH CH155277A patent/CH598230A5/xx not_active IP Right Cessation
- 1977-02-09 BE BE174792A patent/BE851255A/xx not_active IP Right Cessation
- 1977-02-11 CA CA271,577A patent/CA1064495A/en not_active Expired
- 1977-02-11 AR AR266526A patent/AR215879A1/es active
- 1977-02-14 PT PT66191A patent/PT66191B/pt unknown
- 1977-02-14 AT AT96677A patent/AT353277B/de not_active IP Right Cessation
- 1977-02-14 NL NL7701522A patent/NL167962C/xx not_active IP Right Cessation
- 1977-02-16 US US05/769,403 patent/US4073895A/en not_active Expired - Lifetime
- 1977-02-16 ES ES455945A patent/ES455945A1/es not_active Expired
- 1977-02-17 DK DK68177AA patent/DK142363B/da not_active IP Right Cessation
- 1977-02-18 DE DE2707095A patent/DE2707095C3/de not_active Expired
- 1977-02-18 FR FR7704658A patent/FR2341571A1/fr active Granted
- 1977-02-18 FR FR7704659A patent/FR2341315A1/fr active Granted
- 1977-02-18 JP JP52016314A patent/JPS5928548B2/ja not_active Expired
-
1979
- 1979-08-23 HK HK590/79A patent/HK59079A/xx unknown
-
1980
- 1980-12-31 MY MY198069A patent/MY8000069A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK142363B (da) | Analogifremgangsmåde til fremstilling af 2-isopropylaminopyrimidinorthophosphat. | |
| CA1095930A (en) | Process for the preparation of new derivatives of taurine having a reinforced neuro-muscular activity | |
| NO761208L (cg-RX-API-DMAC10.html) | ||
| DE3780276T2 (de) | Angstloesende n-(1-azabicyclo(2.2.2)oct-3-yl)benzamide und -thiobenzamide. | |
| CA2208351C (en) | Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours | |
| JPS62148488A (ja) | 新規な４Ｈ―トリアゾロ〔４，３―ａ〕〔１，４〕ベンゾジアゼピン類、それらの製造法及び薬剤としての使用 | |
| DE69523914T2 (de) | Pyridylbisphosphonate als therapeutische wirkstoffe | |
| JPS591458A (ja) | ベンズヒドリルスルフイニルアセトヒドロキサム酸誘導体、その製造方法およびこの誘導体を有効成分とする中枢神経系治療剤 | |
| Seth et al. | Design, synthesis, evaluation and computational studies of nipecotic acid-acetonaphthone hybrids as potential antiepileptic agents | |
| NL8002271A (nl) | Werkwijze ter bereiding van isopropylaminopyrimidine- hydroxyderivaten. | |
| FI68045B (fi) | Foerfarande foer framstaellning av terapeutiskt verkande 2-isopropylamino-5-fluor-pyrimidin | |
| DE10127922A1 (de) | Verwendung von phosphororganischen Hydroxamsäurederivaten zur Herstellung von Arzneimitteln für die therapeutische und prophylaktische Behandlung von Infektionen | |
| RS51219B (sr) | Postupak za reagovanje alkaloida i upotreba proizvoda reakcije za dobijanje medikamenata | |
| Bennett et al. | Vitamin B6--phosphonic acids | |
| RU2665037C2 (ru) | Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира | |
| EA020801B1 (ru) | Гомо- и гетерополиаминокислотные производные фуллерена с, способ их получения и фармацевтические композиции на их основе | |
| JP6887195B1 (ja) | 新規有機ゲルマニウム化合物 | |
| PL184934B1 (pl) | Fosforowe pochodne cytyzyny i ich zastosowanie | |
| CS208131B2 (en) | Method of making the new derivatives of the 1,3-benzoxazine-2,4-dione | |
| US3803229A (en) | Amides of 1-aminocyclopentane-carboxylic acid | |
| CN107098930B (zh) | 1-乙酰胺基乙叉-1,1-二膦酸盐及其制备方法与应用 | |
| NO159082B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive phenantrenmetanol-derivater. | |
| Kehl | Muscle relaxant action of β‐hydroxylamine cinnamonyl hydroxamic acid in isolated organs | |
| US3652592A (en) | 2-halo-4-oxo-4 5 6 7-tetrahydroindoles and methods of preparing same | |
| KR101714575B1 (ko) | 피리디니움 옥심 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |